InsiderTrades

Form 4 for TNYA Tenaya Therapeutics, Inc.

Accepted 2026-09-11 20:10:47 ET · period of report 2026-09-10 · accession 0001193125-26-389563 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-09-11 20:10 2026-09-10 TNYA Ali Faraz CEO, Dir A - Grant $0.00 +122.0K 539.8K +29% $0
D 2026-09-11 20:10 2026-09-10 TNYA Ali Faraz CEO, Dir A - Grant $0.00 +732.5K 732.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-10 A A 122,000 $0.00 539,782 D — — (F1) Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock. (F2) The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested. (F3) Includes 384,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
2 Derivative Stock Option (Right to buy) 2026-09-10 A A 732,500 $0.00 732,500 D $0.6488 · 2026-10-10 to 2036-09-09 732,500 Common Stock (F4) Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.